Clinical usefulnessWhen should parapneumonic pleural effusions be drained in children?
Introduction
The ancient aphorism “Ubi pus ibi evacua” still stands as a general guide for treating the presence of pus in the pleural space [1]. The key question that remains to be answered is which parapneumonic pleural effusions (PPE) will evolve into pus. Numbers vary, but the annual incidence of PPE has been increasing over the last twenty years, with cohorts reporting changes from 1 to 5 per 100,000 children in the USA [2] and 19 to 35 per 100,000 in Spain [3]. Reports from the UK suggests a doubling incidence of up to 3 per 100,000 [4], even though there had been a decrease in the incidence of both pneumonia and pleural effusion after implementing the pneumococcal vaccination [5]. Parapneumonic pleural effusions are common in paediatric pneumonia, with 5–40% of children having this complication [6]. However, the majority of effusions are small and don’t need further investigation or a therapeutic approach different than systemic antibiotics [7]. Contrary to what is reported in adults, pleural effusions in children, complicated or not, are rarely associated with non-bacterial pneumonia, and Streptococcus pneumoniae remains, worldwide, the most common bacteria causing PPE in children [8].
The diagnosis of PPE is usually based on clinical findings and consistent imaging provided by a chest X-Ray (CXR) initially and selectively with chest ultrasound (U/S) and Computed tomography of the chest [9]. CXRs are still the mainstay for the initial diagnosis, but adding U/S has the advantage of estimating the depth and location of the PPE and the presence of septation in the pleural space. This will influence the decision for additional treatment besides antibiotics. There is an increasing use of U/S in clinical settings for this purpose, as well as for accurately guiding thoracentesis [10], [11]. Nevertheless, as a highly operator-dependant technique, proper training should first be undertaken in the use of U/S undertaken to avoid potential diagnostic and therapeutic errors. Computed tomography of the chest is called upon in complex or difficult cases where a more detailed thoracic and pulmonary assessment is needed.
Light’s criteria have been used for decades, in children and adults to decide when is appropriate to drain the contents of the pleural space. They were devised to estimate the stage of the PPE which, in turn, would suggest if the effusion was complicated or non-complicated. Basically, a non-complicated PPE is characterized by a pH > 7.20, glucose > 40 mg/dL and Lactate Dehydrogenase [LDH] < 1000 U/L. In contrast, a complicated PPE is characterized by a pH ≤ 7.2, glucose ≤ 40 mg/dL and LDH ≥ 1000 U/L. PPE with pus (empyema) or bacteria identified in the pleural fluid should also be considered as a complicated PPE [12]. Non-complicated PPEs are treated with systemic antibiotics and complicated PPEs need drainage in addition to antibiotics. Nonetheless, it’s important to acknowledge that Light’s criteria were originally based on adult studies, and they have been applied in paediatrics without properly confirming its full validity in children [13]. However, time seems to have given enough credit to its implementation, as many hospitals worldwide still use them for decision making in paediatric PPE with good results [14], [15]. Our published data already showed that, in children, the sensitivity and specificity of pleural fluid pH and glucose were, respectively, high and similar to what has been found in adult studies regarding PPEs that needed drainage [14].
Certainly, the most important decision that clinicians face with PPE in children is whether it needs to be drained or not. If so, when is the right time to do it? [16], [17]. The majority of studies published have relied on Light’s criteria to decide upon surgical intervention. However, some prominent thoracic and surgical societies have publicly taken a stand against the value of these criteria and have recommended a more invasive approach. For instance, the guidelines from the British Thoracic Society [13] and the Thoracic Society of Australia and New Zealand [18] do not favour the use of pleural fluid biochemical analysis, claiming there is not enough evidence supporting its use in children (only in adults). However, there is no evidence against it either. The American Pediatric Surgery Association (APSA) does not recommend using Light’s criteria, but that recommendation was apparently based on a single observational study with questionable validity of results [19]. On the other hand, although the Pediatric Infectious Disease Society and the Infectious Disease Society of America PIDS/IDSA guidelines consider that evidence supporting the use of pleural fluid analysis is low-quality, they do recommend collecting the fluid, by means of a simple thoracentesis, to guide antibiotics and/or more invasive management [20]. The different management strategies are depicted in Fig. 1.
Section snippets
Unanswered questions
There are unanswered questions concerning the diagnostic and therapeutic management of PPE. Some depend on the unavoidable dilemma of affluent versus non-affluent countries regarding costs, quality, availability of and access to resources, both technological and human. Other questions, concern us all:
- 1.
Is chest U/S ready for widespread use, acknowledging its inherent limitations (operator-dependent reliability)? [21].
- 2.
How does one deal with the dilemma of added sedation when managing PPE? If two
Actual trends in PPE management
- •
Management trends in paediatric PPE seem to have been tailored around known limitations and unanswered questions on the issue. They have also been based on some indirect evidence, as seen with the growth of U/S performed by clinicians, cost-reducing measures and new diagnostic bio-molecular methods.
- •
The use of chest U/S is increasing in emergency departments and intensive care unit settings through the implementation of the POCUS (point of care ultrasound) strategy. An important use of this tool
Conclusion
Parapneumonic pleural effusion is still a serious health problem in children, despite the introduction of vaccine coverage for Haemophylus influenza type B and for the main genotypes of streptococcus pneumoniae causing pneumonia. Whether due to other serotypes (considered less common) assuming the active role of those included in the different vaccine presentations [35], or to a combination of factors is yet to be fully elucidated. PPE is still occurring both in affluent and less affluent
Educational aims
The reader will come to appreciate that:
- •
Despite broader vaccination uptake against more pneumococcal serotypes, parapneumonic effusions remain common.
- •
That there is limited evidence to guide best practice management of parapneumonic pleural effusions in children.
- •
The decision to drain pleural fluid in the setting of pneumonia is based upon a range of clinical and imaging criteria rather than biological criteria, such as Light’s criteria.
- •
Large multicentre studies are needed in both the developed
References (36)
Invited commentary
Ann Thorac Surg
(2009)- et al.
Management of parapneumonic effusions
Clin Chest Med
(1998) - et al.
Clinical characteristics of 323 children with parapneumonic pleural effusion and pleural empyema due to community acquired pneumonia
J Infect Chemother
(2016) - et al.
The diagnosis and management of empyema in children: a comprehensive review from the APSA Outcomes and Clinical Trials Committee
J Pediatr Surg
(2012) - et al.
Pleural effusion with negative culture: a challenge for pneumococcal diagnosis in children
Diagn Microbiol Infect Dis
(2016) - et al.
Childhood parapneumonic effusions: biochemical and inflammatory markers
Chest
(2005) - et al.
Trends in treatment of infectious parapneumonic effusions in U.S. children’s hospitals, 2004–2014
J Pediatr Surg
(2016) - et al.
Comparison of pigtail catheter with chest tube for drainage of parapneumonic effusion in children
Pediatr Neonatol
(2011) - et al.
Trends in treatment of infectious parapneumonic effusions in US children’s hospitals, 2004–2014
J Pediatr Surg
(2016) - et al.
Complicated pleural infection: analysis of 2 consecutive cohorts managed with a different policy
An Pediatr (Barcelona)
(2016)
Clinical and bacteriological characteristics of invasive pneumococcal disease after pneumococcal 10-valent conjugate vaccine implementation in Salvador, Brazil
Braz J Infect Dis
An epidemiological investigation of a sustained high rate of pediatric parapneumonic empyema: risk factors and microbiological associations
Clin Infect Dis
Pediatric parapneumonic pleural effusion: epidemiology, clinical characteristics, and microbiological diagnosis
Pediatr Pulmonol
South West of England Invasive Community Acquired Infection Study G. Childhood empyema: limited potential impact of 7-valent pneumococcal conjugate vaccine
Pediatr Infect Dis J
Impact of the seven-valent pneumococcal conjugate vaccination (PCV7) programme on childhood hospital admissions for bacterial pneumonia and empyema in England: national time-trends study, 1997–2008
Thorax
Management of severe community-acquired pneumonia of children in developing and developed countries
Thorax
Management of children with empyema: pleural drainage is not always necessary
Pediatr Pulmonol
Pneumococcal empyema and complicated pneumonias: global trends in incidence, prevalence, and serotype epidemiology
Eur J Clin Microbiol Infect Dis
Cited by (11)
Consensus Document on Community-Acquired Pneumonia in Children. SENP-SEPAR-SEIP
2020, Archivos de BronconeumologiaEpigastric Pain and Pleural Effusion in a 12-Year-Old
2023, Clinical PediatricsManagement of parapneumonic pleural effusion and empyema in children: A tale of two cities
2022, Pediatric PulmonologyComplications in community acquired pneumonia: magnitude of problem, risk factors, and management in pediatric age
2022, Expert Review of Anti-Infective TherapyValue of Ultrasonography in the Diagnosis of Pleural Effusion: Analysis of 582 Cases
2021, Research Square